Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer from Ontario and guidelines in general--some observations.

Wong WL, Ross P, Corcoran M.

Clin Oncol (R Coll Radiol). 2013 Apr;25(4):242-5. doi: 10.1016/j.clon.2013.01.004. Epub 2013 Feb 17. No abstract available.

PMID:
23422786
2.

Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.

Yoo J, Henderson S, Walker-Dilks C.

Clin Oncol (R Coll Radiol). 2013 Apr;25(4):e33-66. doi: 10.1016/j.clon.2012.08.007. Epub 2012 Sep 26. Review.

PMID:
23021712
3.

Positron emission tomography/computed tomography imaging of head and neck tumors: an atlas.

Graham MM, Menda Y.

Semin Nucl Med. 2005 Oct;35(4):220-52. No abstract available.

PMID:
16150244
4.

Head and neck: normal variations and benign findings in FDG positron emission tomography/computed tomography imaging.

Højgaard L, Berthelsen AK, Loft A.

PET Clin. 2014 Apr;9(2):141-5. doi: 10.1016/j.cpet.2013.11.002. Review.

PMID:
25030278
5.

Improving target definition for head and neck radiotherapy: a place for magnetic resonance imaging and 18-fluoride fluorodeoxyglucose positron emission tomography?

Prestwich RJ, Sykes J, Carey B, Sen M, Dyker KE, Scarsbrook AF.

Clin Oncol (R Coll Radiol). 2012 Oct;24(8):577-89. doi: 10.1016/j.clon.2012.04.002. Epub 2012 May 15. Review.

PMID:
22592142
7.
8.

Pretreatment positron emission tomography with [18F]fluorodeoxyglucose for head and neck squamous cancer.

Paleri V, Zammit-Maempel I.

J Clin Oncol. 2010 Oct 1;28(28):e515. doi: 10.1200/JCO.2010.29.2144. Epub 2010 Jul 6. No abstract available.

9.

[18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality.

de Souza JA, Cohen EE.

J Clin Oncol. 2010 Oct 1;28(28):e516; author reply e517. doi: 10.1200/JCO.2010.29.6715. Epub 2010 Jul 6. No abstract available.

10.

FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?

Schwartz DL, Macapinlac HA, Weber RS.

J Natl Cancer Inst. 2008 May 21;100(10):688-9. doi: 10.1093/jnci/djn149. Epub 2008 May 13. No abstract available.

11.

Dual-time-point fluorodeoxyglucose positron emission tomography for diagnosis of cervical lymph node metastases in patients with head and neck squamous cell carcinoma.

Nakamura S, Okochi K, Kurabayashi T.

J Comput Assist Tomogr. 2011 Mar-Apr;35(2):303-7. doi: 10.1097/RCT.0b013e31820a0af2.

PMID:
21412108
12.

"Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).

Schinagl DA, Troost EG, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1629; author reply 1629. doi: 10.1016/j.ijrobp.2009.04.035. Epub 2009 Jun 8. No abstract available.

PMID:
19515513
13.

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

Moule RN, Kayani I, Prior T, Lemon C, Goodchild K, Sanghera B, Wong WL, Saunders MI.

Clin Oncol (R Coll Radiol). 2011 Jun;23(5):364-71. doi: 10.1016/j.clon.2010.11.001. Epub 2010 Nov 24.

PMID:
21109410
14.

FDG PET imaging of head and neck cancers.

Menda Y, Graham MM.

Methods Mol Biol. 2011;727:21-31. doi: 10.1007/978-1-61779-062-1_2.

PMID:
21331926
15.

[Head and neck neoplasms--combination PET/CT is better than a single approach].

[No authors listed]

Rofo. 2005 Oct;177(10):1345. German. No abstract available.

PMID:
16170700
16.

[The value of PET-CT imaging in malignant tumours of the head and neck].

Balink H, Krabbe CA, de Visscher JG.

Ned Tijdschr Geneeskd. 2007 May 26;151(21):1167-72. Review. Dutch.

PMID:
17557755
17.

Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer.

Wong R, Walker-Dilks C, Raifu A.

Clin Oncol (R Coll Radiol). 2012 Mar;24(2):86-104. doi: 10.1016/j.clon.2011.09.006. Epub 2011 Sep 29. Review.

PMID:
21962904
18.

The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.

Inohara H, Enomoto K, Tomiyama Y, Yoshii T, Osaki Y, Higuchi I, Inoue T, Hatazawa J.

Acta Otolaryngol. 2009 Aug;129(8):893-9. doi: 10.1080/00016480802441747.

PMID:
18839385
19.

18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.

Xie P, Li M, Zhao H, Sun X, Fu Z, Yu J.

J Cancer Res Clin Oncol. 2011 Jul;137(7):1085-93. doi: 10.1007/s00432-010-0972-y. Epub 2011 Jan 13.

PMID:
21229262
20.

Positron emission tomography scanning in oesophageal cancer - stuck at the first hurdle?

Falk S.

Clin Oncol (R Coll Radiol). 2012 Mar;24(2):83-5. doi: 10.1016/j.clon.2011.08.001. Epub 2011 Aug 23. No abstract available.

PMID:
21865019
Items per page

Supplemental Content

Write to the Help Desk